Freestone Grove Partners LP Acquires Shares of 51,390 Humana Inc. $HUM

Freestone Grove Partners LP acquired a new stake in shares of Humana Inc. (NYSE:HUM) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 51,390 shares of the insurance provider’s stock, valued at approximately $20,413,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Revolve Wealth Partners LLC bought a new position in Humana during the 4th quarter worth approximately $202,000. Woodline Partners LP raised its position in shares of Humana by 460.0% during the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after acquiring an additional 8,372 shares in the last quarter. Sivia Capital Partners LLC raised its position in shares of Humana by 53.7% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after acquiring an additional 452 shares in the last quarter. Cresset Asset Management LLC lifted its stake in Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after purchasing an additional 222 shares during the last quarter. Finally, WINTON GROUP Ltd boosted its holdings in Humana by 58.5% in the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after purchasing an additional 879 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Performance

Shares of NYSE HUM opened at $392.72 on Friday. The company has a market cap of $47.16 billion, a PE ratio of 37.15, a P/E/G ratio of 2.23 and a beta of 0.72. The stock has a 50 day simple moving average of $385.08 and a 200-day simple moving average of $287.78. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. Humana’s quarterly revenue was up 26.2% on a year-over-year basis. During the same quarter last year, the company earned $6.27 EPS. On average, equities research analysts forecast that Humana Inc. will post 9.12 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on HUM. JPMorgan Chase & Co. raised their price target on shares of Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research report on Monday, August 10th. Lake Street Capital started coverage on shares of Humana in a report on Thursday, July 30th. They issued a “buy” rating on the stock. HSBC downgraded Humana to a “hold” rating in a research note on Thursday, July 30th. Robert W. Baird set a $390.00 price target on Humana in a research report on Thursday, July 30th. Finally, Bank of America raised Humana from a “neutral” rating to a “buy” rating and set a $500.00 price target on the stock in a report on Wednesday, July 29th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $403.91.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.